Patents Represented by Attorney Arthur R. Whale
  • Patent number: 4552967
    Abstract: The present invention relates to a process for preparing aminonitropyridines comprising reacting an alkoxynitropyridine with ammonium acetate.
    Type: Grant
    Filed: January 12, 1984
    Date of Patent: November 12, 1985
    Assignee: Eli Lilly and Company
    Inventors: James M. Greene, Edward R. Lavagnino, Andrew J. Pike, Edward C. Taylor
  • Patent number: 4552982
    Abstract: 9-Carbamoyl-9-(2-cyanoethyl)fluorenes are converted to 9-carbamoyl-9-(3-aminopropyl)fluorenes by catalytic hydrogenation in the presence of a strong acid.
    Type: Grant
    Filed: August 1, 1983
    Date of Patent: November 12, 1985
    Assignee: Eli Lilly and Company
    Inventors: William B. Lacefield, William Pfeifer
  • Patent number: 4552891
    Abstract: This invention provides for pharmaceutical formulations of certain benzothiophene derivatives and a method of using the derivatives or formulations for the treatment of asthma.
    Type: Grant
    Filed: September 13, 1983
    Date of Patent: November 12, 1985
    Assignee: Eli Lilly and Company
    Inventors: Peter P. K. Ho, Quentin F. Soper
  • Patent number: 4552895
    Abstract: The invention provides for certain compounds derived from ascorbic acid and their formulations which are useful in inhibiting angiogenesis in mammals.
    Type: Grant
    Filed: March 14, 1983
    Date of Patent: November 12, 1985
    Assignee: Eli Lilly and Company
    Inventors: Gary A. Koppel, Russell L. Barton, Stephen L. Briggs
  • Patent number: 4552956
    Abstract: Pyrazolo, pyrimido and thiazolo[1,4]benzoxazines, useful as dopamine agonists.
    Type: Grant
    Filed: August 15, 1984
    Date of Patent: November 12, 1985
    Assignee: Eli Lilly and Company
    Inventors: Richard N. Booher, Edmund C. Kornfeld
  • Patent number: 4552886
    Abstract: N-Thiazolyl heterocyclic amines, useful as fungicides and aquatic plant growth regulators.
    Type: Grant
    Filed: March 7, 1983
    Date of Patent: November 12, 1985
    Assignee: Eli Lilly and Company
    Inventors: Eriks V. Krumkalns, David L. Smiley
  • Patent number: 4548924
    Abstract: Antibiotics M43B and M43C, new glycopeptide antibiotics of the vancomycin class, are produced by Nocardia orientalis NRRL 2452. M43B and M43C have antibacterial activity.
    Type: Grant
    Filed: April 16, 1984
    Date of Patent: October 22, 1985
    Assignee: Eli Lilly and Company
    Inventor: Karl H. Michel
  • Patent number: 4548925
    Abstract: Antibiotic M43A, a new glycopeptide antibiotic of the vancomycin class, is produced by Nocardia orientalis strains NRRL 2450 and NRRL 2452. M43A has excellent antibacterial activity comparable to that of vancomycin.
    Type: Grant
    Filed: April 16, 1984
    Date of Patent: October 22, 1985
    Assignee: Eli Lilly and Company
    Inventors: Harvey M. Higgins, Jr., Kurt E. Merkel, Mack H. McCormick
  • Patent number: 4547488
    Abstract: Antibiotic M43D, a new glycopeptide antibiotic of the vancomycin class, is produced by Nocardia orientalis NRRL 2450. M43D has excellent antibacterial activity comparable to that of vancomycin.
    Type: Grant
    Filed: April 16, 1984
    Date of Patent: October 15, 1985
    Assignee: Eli Lilly and Company
    Inventor: Kurt E. Merkel
  • Patent number: 4544752
    Abstract: 3-Phenyl (or meta or para-substituted phenyl)-4-permissibly substituted-5-isothiazolecarboxylic acids, salts, esters and simple amides, used to lower uric acid levels in mammals.
    Type: Grant
    Filed: June 6, 1983
    Date of Patent: October 1, 1985
    Assignee: Eli Lilly and Company
    Inventors: James R. Beck, Robert P. Gajewski, Ronald E. Hackler
  • Patent number: 4542131
    Abstract: Compounds are described of the formula ##STR1## or an acid addition salt thereof; in which R.sup.1, R.sup.2, R.sup.3 and R.sup.4 independently represent hydrogen, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.3-7 cycloalkyl, C.sub.3-7 cycloalkyl C.sub.1-4 alkyl, halogen, C.sub.1-4 haloalkyl, C.sub.1-4 alkanoyl, nitro, amino, C.sub.2-4 acylamino, cyano, hydroxyl, C.sub.1-4 alkoxy, C.sub.1-4 alkylthio, C.sub.1-4 haloalkoxy or a group of the formula --SO.sub.2 N(R.sup.8).sub.2, --SO.sub.2 R.sup.8 or --SO.sub.3 R.sup.8 where R.sup.8 is C.sub.1-4 alkyl, C.sub.1-4 haloalkyl or optionally substituted phenyl; in which R.sup.5 is a group of the formula ##STR2## where R.sup.9 is hydrogen, C.sub.1-4 alkyl, C.sub.3-7 cycloalkyl, C.sub.3-7 cycloalkyl C.sub.1-4 alkyl, C.sub.1-4 haloalkyl, C.sub.2-4 alkenyl, C.sub.1-4 alkanoyl, benzyl, cyano or optionally substituted phenyl, where R.sup.10 is hydrogen, C.sub.1-4 alkyl or optionally substituted phenyl and where n is 0 or 1; in which R.sup.6 is hydrogen, C.sub.1-10 alkyl, C.sub.
    Type: Grant
    Filed: August 6, 1984
    Date of Patent: September 17, 1985
    Assignee: Lilly Industries Limited
    Inventors: Jiban K. Chakrabarti, Terrence M. Hotten
  • Patent number: 4540779
    Abstract: Crystalline 7-(R)-amino-3-(1'-pyridiniummethyl)-ceph-3-em-4-carboxylate monohydrochloride monohydrate compound is an intermediate in the synthesis of the cephalosporin antibiotic ceftazidime.
    Type: Grant
    Filed: June 20, 1983
    Date of Patent: September 10, 1985
    Assignee: Eli Lilly and Company
    Inventors: Preston C. Conrad, Alvydas A. Jarmas
  • Patent number: 4540787
    Abstract: A process for preparing 1-alkyl-6-oxodecahydroquinolines in 5 steps--a quaternization, hydrogenation, two organometallic reductions and hydrolysis of the thus formed enol ether--from 6-alkyloxyquinoline and intermediates useful therein.
    Type: Grant
    Filed: August 10, 1983
    Date of Patent: September 10, 1985
    Assignee: Eli Lilly and Company
    Inventor: John M. Schaus
  • Patent number: 4539422
    Abstract: A process for preparing a C.sub.3 -C.sub.8 alkyl cyanoformate derivative employing a liquid-liquid phase transfer catalysis conducted at low temperatures.
    Type: Grant
    Filed: February 22, 1985
    Date of Patent: September 3, 1985
    Assignee: Eli Lilly and Company
    Inventor: Ian G. Wright
  • Patent number: 4537965
    Abstract: 4aR,8aR-5-permissibly substituted-6-oxo-octahydro-1H(and 2H)-pyrazolo[3,4-g]quinolines. The compounds are useful as intermediates in preparing dopamine D-2 agonists.
    Type: Grant
    Filed: August 3, 1984
    Date of Patent: August 27, 1985
    Assignee: Eli Lilly and Company
    Inventor: Nancy G. Gallick-Whitaker
  • Patent number: 4537893
    Abstract: Trans-(.+-.) 2 and/or 5-permissibly substituted octahydrothiazolo[4,5-g]quinolines and acid addition or quaternary salts thereof and, individual enantiomers thereof, useful as dopamine agonists.
    Type: Grant
    Filed: April 27, 1984
    Date of Patent: August 27, 1985
    Assignee: Eli Lilly and Company
    Inventors: Robert D. Titus, Edmund C. Kornfeld
  • Patent number: 4537889
    Abstract: This invention provides for certain phenyl-substituted imidazo compounds, their pharmaceutical formulations, and their use as positive inotropic agents and vasodilators.
    Type: Grant
    Filed: May 3, 1984
    Date of Patent: August 27, 1985
    Assignee: Eli Lilly and Company
    Inventor: Wayne A. Spitzer
  • Patent number: 4537879
    Abstract: Antibiotic A47934 is produced by submerged, aerobic fermentation of new Streptomyces toyocaensis NRRL 15009. The antibiotic is active against gram-positive bacteria in vitro and in vivo. It promotes growth in poultry and swine and serves to enhance feed efficiency in ruminant animals having a developed rumen.
    Type: Grant
    Filed: June 22, 1984
    Date of Patent: August 27, 1985
    Assignee: Eli Lilly and Company
    Inventors: Robert L. Hamill, Ralph E. Kastner
  • Patent number: 4537727
    Abstract: A process is described for recovering 2-acetylthiomethyl-5-aminopentanoic acid from an impure acid addition salt thereof by treating the latter in a polar organic solvent with a base.
    Type: Grant
    Filed: November 12, 1982
    Date of Patent: August 27, 1985
    Assignee: Eli Lilly and Company
    Inventors: Russell L. Barton, Stephen L. Briggs, Gary A. Koppel
  • Patent number: 4537957
    Abstract: 23-Demycinosyltylosin (DMT) which has the formula: ##STR1## 20-dihydro-DMT, specified acyl ester derivatives, and their acid addition salts are useful antibacterial agents. Improved methods of making 5-O-mycaminosyltylonolide (OMT) and 20-dihydro-OMT by mild acid hydrolysis of DMT and 20-dihydro-DMT, respectively, are included.
    Type: Grant
    Filed: June 13, 1983
    Date of Patent: August 27, 1985
    Assignee: Eli Lilly and Company
    Inventors: Richard H. Baltz, Gene M. Wild, Eugene T. Seno